UK Markets closed

Mereo BioPharma Group plc (MREO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.5300+0.1200 (+8.51%)
At close: 04:00PM EDT
1.5300 0.00 (0.00%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 1.47
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 33.2700
52-week low 30.3010
50-day moving average 30.6898
200-day moving average 31.4565

Share statistics

Avg vol (3-month) 34.8M
Avg vol (10-day) 323.46M
Shares outstanding 5108.9M
Implied shares outstanding 6N/A
Float 845.74M
% held by insiders 10.05%
% held by institutions 177.57%
Shares short (28 Apr 2022) 46.85M
Short ratio (28 Apr 2022) 47.93
Short % of float (28 Apr 2022) 4N/A
Short % of shares outstanding (28 Apr 2022) 45.85%
Shares short (prior month 30 Mar 2022) 47.06M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021


Profit margin 34.90%
Operating margin (ttm)-57.42%

Management effectiveness

Return on assets (ttm)-13.82%
Return on equity (ttm)34.85%

Income statement

Revenue (ttm)36.46M
Revenue per share (ttm)0.34
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)18.56M
EBITDA -20.86M
Net income avi to common (ttm)12.72M
Diluted EPS (ttm)-0.3560
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)94.3M
Total cash per share (mrq)0.81
Total debt (mrq)16.76M
Total debt/equity (mrq)19.05
Current ratio (mrq)7.92
Book value per share (mrq)0.82

Cash flow statement

Operating cash flow (ttm)-5.24M
Levered free cash flow (ttm)-6.7M